Nlrp3 Inflammasome Activation in Type 2 Diabetes: Is It Clinically Relevant?
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Aberrant activation of the innate immune systemin metabolic disorders such as type 2 diabeteshas been recognized to be an important mecha-nism of disease pathogenesis (1–3). Emergence of a chronic proinflammatory state driven by the activation of myeloid lineage innate immune cells, such as macro-phages and neutrophils, has been directly linked to the emergence of insulin resistance (4,5). Until recently, the identity of specific innate immune pattern recognition re-ceptors or sensors that recognize diverse metabolic “danger signals ” to initiate a proinflammatory cascade during obe-sity and diabetes was unknown. Pioneering studies from Tschopp and colleagues (6) identified that “inflamma-somes, ” the multiprotein cytosolic molecular platforms in myeloid cells, can sense damage-associated molecular pat-terns (DAMPs) and control the secretion of proinflam-matory cytokines interleukin (IL)-1b and IL-18 in metabolic stress. Structurally, inflammasomes consist of a Nod-like
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have demonstrated important roles of the NLRP3 inflammasome in aging and age-related diseases, such as atherosclerosis metabolic syndrome, type 2 diabetes, and Alzheimer’s disease (81–83).”
From Connecting aging biology and inflammation in the omics era (2022) · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737 · cited 2×
“This clinical trial reported increased b-cell secretory capacity but did not detect any changes in insulin resistance despite reduction in serum C-reactive protein (3).”
BackgroundCryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080 · cited 1×
“The release of ATP from necrotic cells is also a potent trigger of inflammasome activation (14).”
BackgroundSelf-citationEndoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802 · cited 1×
“Metabolic distress, inflammation, and development of insulin-resistance are linked to increased oxidative stress emerging from mitochondria and unfolded protein response due to defective endoplasmic reticulum function (6,17).”
BackgroundThioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708 · cited 1×
“Consistent with studies in animal models (18), Lee et al.”
ResultThe NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Self-citationFatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698 · cited 2×
“Together with prior studies from Ting and colleagues (8), the current data from myeloid cells of type 2 diabetic patients corroborate the earlier findings that inhibition of AMP-activated protein kinase can exacerbate reactive oxygen species–dependent Nlrp3 inflammasome activation (11).”
BackgroundResultMacrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314 · cited 1×
“Emergence of a chronic proinflammatory state driven by the activation of myeloid lineage innate immune cells, such as macrophages and neutrophils, has been directly linked to the emergence of insulin resistance (4,5).”
BackgroundThe NLRP3 Inflammasome: A Sensor for Metabolic Danger?
Schroder, K., Zhou, R., & Tschopp, J. (2010) · Science · doi:10.1126/science.1184003 · Cited by 1,134 · cited 11×
“The knockdown of Nlrp3 and Asc via RNA interference in myeloid cells of type 2 diabetic patients prevented the ability of metabolic DAMPs to induce IL-1b and IL-18 secretion (11).”
BackgroundInfluentialNutrient sensing and inflammation in metabolic diseases
Hotamisligil, G. S., & Erbay, E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2449 · Cited by 1,040
Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase
Talukdar, S., Oh, D. Y., Bandyopadhyay, G., Li, D., Xu, J., McNelis, J., Lu, M., Li, P., Yan, Q., Zhu, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2885 · Cited by 960 · cited 1×
“Emergence of a chronic proinflammatory state driven by the activation of myeloid lineage innate immune cells, such as macrophages and neutrophils, has been directly linked to the emergence of insulin resistance (4,5).”
BackgroundLerner, A. G., Upton, J.-P., Praveen, P. V. K., Ghosh, R., Nakagawa, Y., Igbaria, A., Shen, S., Nguyen, V., Backes, B. J., Heiman, M., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.007 · Cited by 846
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Lee, H.-M., Kim, J.-J., Kim, H. J., Shong, M., Ku, B. J., & Jo, E.-K. (2013) · Diabetes · doi:10.2337/db12-0420 · Cited by 734 · cited 7×
“The knockdown of Nlrp3 and Asc via RNA interference in myeloid cells of type 2 diabetic patients prevented the ability of metabolic DAMPs to induce IL-1b and IL-18 secretion (11).”
BackgroundResultInfluentialInflammasome is a central player in the induction of obesity and insulin resistance
Stienstra, R., van Diepen, J. A., Tack, C. J., Zaki, M. H., van de Veerdonk, F. L., Perera, D., Neale, G. A., Hooiveld, G. J., Hijmans, A., Vroegrijk, I., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100255108 · Cited by 727
Stienstra, R., Joosten, L. A. B., Koenen, T., van Tits, B., van Diepen, J. A., van den Berg, S. A. A., Rensen, P. C. N., Voshol, P. J., Fantuzzi, G., Hijmans, A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.011 · Cited by 676
Immunological complications of obesity
Kanneganti, T.-D., & Dixit, V. D. (2012) · Nature Immunology · doi:10.1038/ni.2343 · Cited by 478 · cited 1×
“Depending on specific DAMPs that are encountered by a myeloid lineage cells, several mechanisms control the assembly and activation of the Nlrp3 inflammasome (2).”
BackgroundSelf-citationChalkiadaki, A., & Guarente, L. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.07.003 · Cited by 352 · cited 1×
“Interestingly, recent work demonstrates that high-fat diet feeding–induced caspase-1 deactivates Sirtuin 1 and leads to insulin resistance (23).”
BackgroundDifferential Expression of NLRP3 among Hematopoietic Cells
Guarda, G., Zenger, M., Yazdi, A. S., Schroder, K., Ferrero, I., Menu, P., Tardivel, A., Mattmann, C., & Tschopp, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002720 · Cited by 350 · cited 1×
“The studies from knock-in reporter mice in which Nlrp3 coding sequence is substituted with green fluorescent protein demonstrate that the Nlrp3 inflammasome is predominantly active in myeloid cells (12).”
BackgroundElimination of the NLRP3-ASC Inflammasome Protects against Chronic Obesity-Induced Pancreatic Damage
Youm, Y.-H., Adijiang, A., Vandanmagsar, B., Burk, D., Ravussin, A., & Dixit, V. D. (2011) · Endocrinology · doi:10.1210/en.2011-1326 · Cited by 174 · cited 1×
“Importantly, ablation of Nlrp3 and Asc in chronically obese mice leads to increased islet size and protection of b-cells in pancreatic islets from inflammationinduced death (19).”
BackgroundSelf-citationHyperglycemia Activates Caspase-1 and TXNIP-Mediated IL-1β Transcription in Human Adipose Tissue
Koenen, T. B., Stienstra, R., van Tits, L. J., de Graaf, J., Stalenhoef, A. F. H., Joosten, L. A. B., Tack, C. J., & Netea, M. G. (2011) · Diabetes · doi:10.2337/db10-0266 · Cited by 172 · cited 1×
“Also, earlier studies have reported that hyperglycemia induces caspase-1 activation in adipose tissue and adipocytes (20).”
BackgroundGoossens, G. H., Blaak, E. E., Theunissen, R. O. M. F. I. H., Duijvestijn, A. M., Clément, K., Tervaert, J.-W. C., & Thewissen, M. M. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.01.005 · Cited by 120 · cited 1×
“Studies using human adipose biopsies have shown an association between increased caspase-1 and Nlrp3 inflammasome activity to insulin resistance (21).”
BackgroundUric Acid as a Mediator of Diabetic Nephropathy
Jalal, D. I., Maahs, D. M., Hovind, P. H., & Nakagawa, T. (2011) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2011.08.011 · Cited by 115 · cited 1×
“The increased levels of elevated free fatty acids that induce lipotoxicity (7,8) and higher uric acid levels (13) are known to increase the risk of development of diabetes and its complications.”
Background
Research works printed but not linked: 1
- XOMA 052 phase 2b top line results:, Glucose control not demonstrated, positive anti-inflammatory effect, cardiovascular biomarker and lipid improvement and safety confirmed [press release online], 2011
Cited by
Ye, Y., Bajaj, M., Yang, H.-C., Perez-Polo, J. R., & Birnbaum, Y. (2017) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-017-6725-2 · Cited by 368
McElwain, C. J., Tuboly, E., McCarthy, F. P., & McCarthy, C. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00655 · Cited by 208
SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway
Xu, H., Akinyemi, I. A., Chitre, S. A., Loeb, J. C., Lednicky, J. A., McIntosh, M. T., & Bhaduri-McIntosh, S. (2022) · Virology · doi:10.1016/j.virol.2022.01.003 · Cited by 176
“…such as diabetes, atherosclerosis, and obesity (all pro-inflammatory conditions marked by NLRP3 activation) (Chen et al., 2017; Dixit, 2013; Grant; Dixit, 2013; Jin and Fu, 2019; Rheinheimer et al., 2017; Stienstra et al., 2011) are at greater risk for severe disease (Richardson et al.,…”
Connecting aging biology and inflammation in the omics era
Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158448 · Cited by 189
Corcoran, S. E., Halai, R., & Cooper, M. A. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000171 · Cited by 173
Metadata
- Authors
- Dixit, V. D.
- Affiliations
- Pennington Biomedical Research Center (US)
- Corresponding author
- Dixit, Vishwa Deep
- ORCID
- Dixit, Vishwa Deep
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-12-13
- Volume
- 62
- Issue
- 1
- Pages
- 22-24
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3526045
- OpenAlex
- W2130502531
- Cited by
- 85
- References
- 22
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 2 · 2023: 8 · 2022: 11 · 2021: 8 · 2020: 11 · 2019: 4 · 2018: 7 · 2017: 5 · 2016: 5 · 2015: 3 · 2014: 4 · 2013: 4
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG031797)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK090556, P30DK072476)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP3 inflammasome, type 2 diabetes, innate immunity, insulin resistance, inflammation, myeloid cells, macrophages, neutrophils, damage-associated molecular patterns, IL-1β, IL-18, obesity, metabolic stress
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Carrier Proteins, Diabetes Mellitus, Type 2, Female, Humans, Male, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.